JBCHEPHARM - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.9
| Stock Code | JBCHEPHARM | Market Cap | 33,512 Cr. | Current Price | 2,085 ₹ | High / Low | 2,177 ₹ |
| Stock P/E | 46.1 | Book Value | 238 ₹ | Dividend Yield | 0.74 % | ROCE | 25.9 % |
| ROE | 20.2 % | Face Value | 1.00 ₹ | DMA 50 | 1,986 ₹ | DMA 200 | 1,830 ₹ |
| Chg in FII Hold | -0.76 % | Chg in DII Hold | -0.12 % | PAT Qtr | 179 Cr. | PAT Prev Qtr | 200 Cr. |
| RSI | 57.4 | MACD | 43.1 | Volume | 3,04,331 | Avg Vol 1Wk | 5,02,548 |
| Low price | 1,303 ₹ | High price | 2,177 ₹ | PEG Ratio | 1.93 | Debt to equity | 0.01 |
| 52w Index | 89.5 % | Qtr Profit Var | 14.6 % | EPS | 46.5 ₹ | Industry PE | 27.2 |
📊 JB Chemicals & Pharmaceuticals (JBCHEPHARM) shows favorable conditions for swing trading. The RSI at 57.4 indicates neutral momentum, while the MACD (43.1) is positive, suggesting bullish signals. The stock is trading above both its 50 DMA (1,986 ₹) and 200 DMA (1,830 ₹), reflecting strength. The optimal entry price would be around 2,000–2,050 ₹. If already holding, consider exiting near 2,150–2,175 ₹, close to the 52-week high, unless momentum continues strongly.
✅ Positive
- Strong ROCE (25.9%) and ROE (20.2%) indicate efficient capital use.
- Low debt-to-equity ratio (0.01) ensures financial stability.
- EPS of 46.5 ₹ shows strong earnings power.
- Dividend yield of 0.74% provides modest income.
⚠️ Limitation
- High P/E ratio (46.1) compared to industry average (27.2).
- PEG ratio of 1.93 suggests valuation is stretched.
- Decline in both FII (-0.76%) and DII (-0.12%) holdings.
- Volume lower than 1-week average, indicating weaker participation.
📉 Company Negative News
- Quarterly PAT declined from 200 Cr. to 179 Cr.
- Valuation appears expensive relative to peers.
📈 Company Positive News
- Quarterly profit variation of 14.6% shows underlying growth momentum.
- EPS growth supports long-term investor confidence.
- Stock trading near 52-week high, reflecting strong investor sentiment.
🏭 Industry
- Industry PE at 27.2 vs. JBCHEPHARM’s PE of 46.1 suggests overvaluation.
- Pharmaceutical sector remains resilient with steady demand and global relevance.
🔎 Conclusion
JB Chemicals & Pharmaceuticals has strong fundamentals and positive technical signals, making it a good candidate for swing trading. Entry near 2,000–2,050 ₹ could be favorable. Exit strategy should target 2,150–2,175 ₹ unless momentum continues. Long-term investors may hold for sectoral resilience, while short-term traders should monitor valuation risks and institutional flows.